Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.20 -1.37 (-4.80%)
At close: Oct 23, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Cost of Revenue (2022 - 2024)

Updated

Amylyx Pharmaceuticals' Cost of Revenue was $5.95 million in FY2024, down 76.6% from $25.44 million in FY2023.

Analysis

Amylyx Pharmaceuticals (AMLX) Cost of Revenue (2022 - 2024) Analysis & Trends

  • Per Business Quant data, Cost of Revenue in earlier years was $25.44 million in FY2023 (+750.0%) and $2.99 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Amylyx Pharmaceuticals 3.03 Bn 1.84 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 8,000.00
Mar 31, 2024 5.95 Mn
Dec 31, 2023 9.36 Mn
Sep 30, 2023 5.22 Mn
Jun 30, 2023 5.58 Mn
Mar 31, 2023 5.28 Mn
Dec 31, 2022 2.82 Mn
Sep 30, 2022 172,000.00
API Access

Amylyx Pharmaceuticals Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=AMLX&period=max&api_key=YOUR_API_KEY